Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07263490 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

Study acronym: PRIOR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 77 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes. Participants will be followed throughout pregnancy with blood samples, blood pressure, clinical controls and ultrasound examinations. Clinical outcomes will be registered post-partum.
Trial Details
NCT Number NCT07263490
Lead Sponsor Copenhagen University Hospital, Hvidovre
Collaborators: Ferring Pharmaceuticals, Gedeon Richter Ltd.
Conditions
(from sponsor)		 Pre-eclampsia, Oocyte Donation, Pre-Eclampsia; Complicating Pregnancy, Pre-Eclampsia; Mild, Pre-Eclampsia, Severe, Pre-eclampsia or Eclampsia With Pre-existing Hypertension, ART, Neonatal Morbidity +7 more
Related terms Abruptio Placentae, Diabetes, Gestational, Fetal Growth Retardation, Hypertension, Pregnancy-Induced, Lymphoma, Follicular, Obstetric Labor, Premature, Postpartum Hemorrhage, Pre-Eclampsia, Pregnancy Complications
Enrollment 462 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov